Literature Library

Research Topics

Educational overviews of peptide and oncology research. Each article opens with a plain-language summary, cites source literature, includes an evidence rating, and clearly notes what remains investigational or unknown.

Safety

Peptide Safety in Oncology Research: What the Literature Shows

The safety of peptides for cancer patients depends entirely on the type of peptide, the form of administration, and the individual's treatment status. Collagen ...

Read article
Regulatory

Peptide Regulatory Status: FDA Approval & Investigational Categories

Most peptides marketed for cancer recovery or as health supplements are NOT FDA approved for those purposes. The FDA has approved specific peptide-based drugs f...

Read article
Recovery

Post-Treatment Nutritional Research: Evidence-Graded Overview

The best supplements after cancer treatment are those that address documented nutritional deficiencies created by treatment, support immune recovery, and have e...

Read article
Education

Collagen vs. Bioactive Peptides: A Research Comparison

Collagen peptides are a specific type of peptide derived from animal collagen protein, broken down into smaller, more digestible fragments. When people in the c...

Read article
Research

BPC-157 in Oncology Research: Preclinical Literature Review

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable tissue-healing proper...

Read article
Research

TB-500 / Thymosin Beta-4: Oncology Research Literature

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide involved in tissue repair, cell migration, and wound healing. While the natural ...

Read article
Recovery

Post-Chemotherapy Research: Published Evidence Overview

Recovery after chemotherapy is a gradual process that typically spans 6 to 12 months, though some effects can persist longer. The most effective recovery strate...

Read article
Nutrition

Protein Research in Post-Treatment Recovery Literature

Safe protein after cancer treatment includes whole food sources like eggs, fish, poultry, legumes, and dairy, supplemented with high-quality protein powders (wh...

Read article
Recovery

Post-Treatment Fatigue: Research Literature Summary

Cancer-related fatigue (CRF) is the most commonly reported side effect of cancer treatment, affecting 60-90% of patients during treatment and 30-60% after treat...

Read article
Recovery

Immune Function Post-Treatment: Research Overview

Supporting immune recovery after cancer treatment requires a multi-faceted approach: adequate nutrition (especially protein and micronutrients), regular physica...

Read article
Peptide Research

Thymosin Alpha 1 for Cancer: What the Research Shows

Thymosin Alpha 1 (TA1) is an immune-modulating peptide that has been approved in over 30 countries as a drug (Zadaxin) for hepatitis B and C. In cancer research...

Read article
Peptide Research

PNC-28: The Tumor-Targeting Peptide Explained

PNC-28 is a synthetic peptide derived from the p53 tumor suppressor protein that has shown remarkable selectivity in targeting cancer cells while leaving health...

Read article
Research Compounds

Fenbendazole and Cancer: Research, Protocols, and What We Know

Fenbendazole is an antiparasitic drug (anthelmintic) that has gained significant attention in cancer research and patient communities after Joe Tippens publicly...

Read article
Research Compounds

Methylene Blue in Cancer Research: Mechanisms and Evidence

Methylene blue is a synthetic dye and pharmaceutical compound with a long history in medicine dating back to the 1800s. In cancer research, methylene blue has s...

Read article
Research Compounds

Acemannan: Aloe Vera's Cancer-Fighting Compound

Acemannan is a polysaccharide (complex sugar molecule) derived from the inner gel of Aloe vera plants. Research has demonstrated that acemannan possesses signif...

Read article
Peptide Oncology

An independent educational platform focused on peptide science, oncology research, and emerging literature. Evidence-graded, research-driven, no medical advice.

Educational content only — not medical advice

Educational Content Only

Information presented on this website is intended solely for educational and research awareness purposes. Peptides discussed may be investigational and may not be approved by the FDA for oncology or other therapeutic use.

No information on this website is intended to diagnose, treat, cure, or prevent any disease. Always consult qualified healthcare professionals regarding medical decisions.

This website may contain affiliate links to laboratory and research supplier directories. We may earn a commission at no additional cost to you. Affiliate relationships do not influence editorial content.

© 2026 Peptide Oncology. All rights reserved.

Emergent badge

Made with Emergent